Nextel Medical Corp (MAJI)
Nextel Medical Corp. is a clinical-stage biotechnology company focused on exploring the therapeutic potential of exosomes in oncology applications in the United States. The company is listed on OTC Markets under the ticker MAJI and its common stock trades on the OTC exchange. It was incorporated in 2010 and is based in Saint Petersburg, Florida. The company was previously known as Exousia Pro, Inc., and adopted its current name in April 2026.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-MAJI
|
—
|
—
|
—
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
September 17, 2026
|
—
|
—
|
—
|
274.637 K
|
—
|
—
|
—
|
—
|
—
|
—
|